Deal Ends Today·Save 35% annual plan
GLP-1 receptor agonistReviewed for 2026 plan year

Does UnitedHealthcare Cover Trulicity?

The verdict

Conditional on most plans

UnitedHealthcare (via OptumRx) covers Trulicity for type 2 diabetes with prior authorization — it is not covered for weight loss. OptumRx distinguishes its GLP-1 coverage by indication: a diabetes track (confirmed T2D + metformin step) and a weight-loss track (BMI ≥30 + comorbidity). Trulicity resolves entirely on the diabetes side. Weight-loss requests for Trulicity are denied because it has no FDA weight-loss indication. Verify coverage on OptumRx or UHC's drug lookup.

MedicareConditional
CommercialConditional
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UnitedHealthcare using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
UnitedHealthcare drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice

Key facts

  • OptumRx routes GLP-1 requests by indication: diabetes track (T2D diagnosis) vs. weight-loss track (BMI-based). Trulicity is diabetes-only; weight-loss requests are denied.

    OptumRx PBM formulary guidance

  • Trulicity (dulaglutide) is FDA-approved for type 2 diabetes and for reducing major adverse cardiovascular events (MACE) in adults with T2D and CV disease.

    FDA Prescribing Information, Trulicity (dulaglutide)

  • The 2026 $2,100 Part D out-of-pocket cap means most continuous Trulicity users on UHC Medicare reach $0 cost within 2–3 months of the plan year.

    CMS Medicare Part D 2026 benefit parameters

Plan types

Medicare vs. commercial coverage

Whether UnitedHealthcare covers Trulicity depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Conditional

UnitedHealthcare Medicare Part D (via OptumRx) covers Trulicity for type 2 diabetes (ICD-10 E11.x) with prior authorization. Specialty/brand tier with 25% coinsurance; continuous users typically reach the 2026 $2,100 Part D annual OOP cap within 2–3 months, then pay $0 for the rest of the year. Trulicity is NOT in the 2026 Medicare GLP-1 Bridge ($50/month, July 1 – Dec 31, 2027) — the Bridge covers only weight-loss GLP-1s. The Lilly $25 savings card is not usable for Medicare members.

Commercial / Employer

Group & marketplace plans

Conditional

UHC commercial/employer plans (OptumRx) cover Trulicity for type 2 diabetes with prior authorization. OptumRx routes confirmed-T2D requests through its diabetes GLP-1 track; requests coded for obesity (E66.x) are routed to the separate AOM/BMI pathway and will be denied for Trulicity. The Lilly Trulicity Savings Card ($25 per 1–3 month fill) is usable for UHC commercial and ACA members — it excludes Medicare and Medicaid. ACA/individual UHC plans cover Trulicity for diabetes only. UHC Community Plan (Medicaid) covers Trulicity for diabetes with PA; state-specific rules apply.

Prior authorization

The 4 boxes you must tick to get approved

Commercial plans that will consider Trulicity require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.

Requirements you meet0 / 4

Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

What you'll pay

Your cost, three ways

What Trulicity actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

Trulicity list price approximately $987/month; retail ~$1,390/month (Drugs.com reference).

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

UHC commercial members can use the Lilly Savings Card for as little as $25 per 1–3 month fill. Without coverage, card caps at $199/month maximum. For UHC Medicare Part D: 25% coinsurance to the 2026 $2,100 annual cap.

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

Lilly Trulicity Savings Card: $25 per fill for commercially insured only (excludes Medicare, Medicaid, TRICARE, VA). MFN deal set a Trulicity reference price of $389/month (implementation timeline varies). Lilly Cares patient assistance for low-income/uninsured.

Reduced copay through the assistance program, where eligible.

All figures are estimates; actual cost depends on plan tier, pharmacy, and deductible status. Confirm via OptumRx or UHC's drug pricing tool.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Search OptumRx or UHC's drug formulary

    Go to UnitedHealthcare.com or OptumRx.com and use the drug search with your plan ID. Look up 'dulaglutide' or 'Trulicity' to see tier placement, prior auth requirements, and estimated copay.

  2. 2

    Confirm you are in the diabetes coverage lane

    Your prescription must be coded with a T2D diagnosis (ICD-10 E11.x) to enter OptumRx's diabetes GLP-1 track. Have your A1c and metformin trial documentation ready. A weight-loss code will be routed to the AOM track and denied for Trulicity.

  3. 3

    Have your prescriber submit the OptumRx prior authorization

    Your doctor submits the PA through OptumRx's system. If approved, check whether the Lilly savings card applies to your plan. If denied, request the appeals process or ask about alternative diabetes GLP-1 options on your formulary.

If it's denied

Options if UnitedHealthcare won't cover Trulicity

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Ozempic (semaglutide)

GLP-1 FDA-approved for type 2 diabetes. OptumRx may position it differently on the formulary — check your specific UHC plan tier.

Mounjaro (tirzepatide)

GIP/GLP-1 agonist FDA-approved for T2D. OptumRx routes Mounjaro on the same diabetes track; not covered for weight loss on standard UHC plans.

Generic metformin

First-line oral diabetes therapy; broadly covered at very low cost. Required step before OptumRx approves a GLP-1.

Compounded semaglutide or tirzepatide (via Curex)

A weight-management option that does not require insurance or prior authorization. Not the same medication as Trulicity.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

OptumRx manages UnitedHealthcare's pharmacy benefit and routes GLP-1s by indication. The diabetes track requires a confirmed T2D diagnosis and metformin step — Trulicity, Ozempic, and Mounjaro live here. The weight-loss track requires BMI ≥30 (or ≥27 with a comorbidity) — Wegovy, Saxenda, and Zepbound live there. A Trulicity request coded for weight loss is routed to the AOM pathway and denied because Trulicity lacks a weight-loss indication.

No. Trulicity is FDA-approved only for type 2 diabetes and cardiovascular risk reduction. UHC and OptumRx will not cover Trulicity for weight loss; requests coded with obesity diagnoses (ICD-10 E66.x) are denied. If weight management is the primary goal, ask your provider about medications that carry an FDA obesity indication and meet OptumRx's BMI-based criteria.

Yes — for UHC commercial and ACA members. The Lilly Trulicity Savings Card lowers cost to as little as $25 per 1–3 month fill (92% of commercially insured pay $30 or less). It explicitly excludes Medicare, Medicaid, TRICARE, and VA. UHC Medicare Part D members cannot use the card; the 2026 $2,100 OOP cap is the main cost-relief mechanism for them.

OptumRx typically requires: confirmed T2D diagnosis (ICD-10 E11.x), recent A1c, and documentation of a metformin trial or contraindication — often plus one additional agent. Your prescriber submits this through OptumRx's PA portal. Using an obesity code will result in a routing mismatch and denial. Specific requirements vary by plan; verify on OptumRx's formulary.

Trulicity has a proven major adverse cardiovascular events (MACE) reduction indication for adults with T2D and established cardiovascular disease or high CV risk — the REWIND trial supported this. This cardiovascular benefit is relevant for Trulicity compared to other diabetes GLP-1s like Ozempic; it may factor into your prescriber's drug choice. Coverage for the CV indication still routes through the standard diabetes T2D prior auth on UHC plans.

The Curex GLP-1 program

A weight-management path that skips insurance and prior auth

Curex offers compounded semaglutide from $49/month and compounded tirzepatide from $149/month at getcurex.com/cl/glp — no insurance and no prior authorization required. This is compounded semaglutide/tirzepatide and is not the same medication as Trulicity. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy. Prescription required, subject to provider review.

Compounded semaglutide
from$49/mo
Weekly injection or oral tablet
Compounded tirzepatide
from$149/mo
Injection or oral tablet
  • Medication + free shipping
  • 24/7 provider access
  • Medical intake & prescription review
From $49/moNo insurance requiredNo prior auth
Build your personalized planPrescription required, subject to provider review.

Compounded semaglutide and tirzepatide are not the same medications as Trulicity and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UnitedHealthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Trulicity and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

Weight care with Curex

A weight-management path that skips insurance and prior auth

Build your personalized plan

Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.